Skip to main content
JIANGSU SIHUAN BIOENGINEERING CO.,LTD logo

JIANGSU SIHUAN BIOENGINEERING CO.,LTD — Investor Relations & Filings

Ticker · 000518 ISIN · CNE0000001P8 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,779 across all filing types
Latest filing 2018-01-05 Regulatory Filings
Country CN China
Listing Shenzhen Stock Exchange 000518

About JIANGSU SIHUAN BIOENGINEERING CO.,LTD

https://www.000518shsw.com

Jiangsu Sihuan Bioengineering Co., Ltd. specializes in the research, development, and production of biopharmaceutical products and traditional Chinese medicines. The company’s core product line features genetic engineering drugs, including recombinant human interleukin-2 (rhIL-2) and recombinant human granulocyte colony-stimulating factor (rhG-CSF). Its manufacturing capabilities encompass various dosage forms such as injections, capsules, and tablets, adhering to rigorous quality standards. In addition to its pharmaceutical core, the company manages ecological restoration and landscape engineering initiatives. The organization focuses on leveraging biotechnology to provide therapeutic solutions for oncology and immune-related conditions, maintaining a commitment to scientific innovation and clinical efficacy.

Recent filings

Filing Released Lang Actions
关于公司部分银行账户被冻结的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by Jiangsu Sihuan Bio Co., Ltd. regarding the freezing of some of the company's bank accounts due to a legal dispute and court order. It details the background of the litigation, the freezing of specific bank accounts, and the company's response and impact on operations. The document is short (1322 characters) and does not contain financial statements, audit opinions, or detailed financial data. It is not a report like an Annual Report, Interim Report, or Earnings Release. It is also not a certification or a voting result announcement. The content is primarily a regulatory announcement about a legal and operational issue affecting the company. Therefore, the most appropriate classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2018-01-05 Chinese
关于公司股东详式权益变动报告书相关内容补充的公告
Major Shareholding Notification Classification · 95% confidence The document is a short announcement regarding a supplementary disclosure related to a detailed equity change report by a shareholder (Wang Hongming). It references an update to a previously disclosed detailed equity change report. The content is about changes in share ownership and related disclosures, not a full report or financial statement. The document length is only 404 characters, indicating it is a brief announcement rather than a full report. This fits the category of Major Shareholding Notification (MRQ), which covers notifications of changes in significant share ownership levels.
2017-12-28 Chinese
详式权益变动报告书
Major Shareholding Notification Classification · 100% confidence The document is titled as a "详式权益变动报告书" which translates to a "Detailed Equity Change Report." It details the change in shareholding of an individual named Wang Hongming in the company 江苏四环生物股份有限公司 (Jiangsu Sihuan Bio Co., Ltd.). The report includes sections on the purpose of the equity change, the method of share acquisition, funding sources, future plans, impact analysis on the company, and related disclosures. It also references relevant Chinese securities laws and regulations concerning equity changes and disclosures. The document is comprehensive and focused on the change in major shareholding, including the increase in shareholding percentage and related legal compliance. This matches the definition of "Major Shareholding Notification (Code: MRQ)" which covers notifications of changes in significant share ownership levels crossing thresholds. The document is not an announcement of a report publication, nor is it a financial report or management report. It is a detailed report on a major shareholding change.
2017-12-28 Chinese
详式权益变动报告书
Major Shareholding Notification Classification · 95% confidence The document is titled "详式权益变动报告书" which translates to "Detailed Equity Change Report". It details the change in shareholding of an individual named Wang Hongming in the company 江苏四环生物股份有限公司 (Jiangsu Sihuan Bioengineering Co., Ltd.). The document includes sections on the purpose of the equity change, the method of change (through large block transactions on the Shenzhen Stock Exchange), the source of funds, future plans, impact analysis on the company, and other related disclosures. It also references compliance with Chinese securities laws and regulations related to equity changes and disclosures. The document is comprehensive and focused on the change in major shareholding and related disclosures. This matches the definition of "Major Shareholding Notification (Code: MRQ)" which involves notification of changes in significant share ownership levels crossing thresholds. The document is not an annual report, audit report, earnings release, or any other category. It is a detailed report on a major shareholding change. The document length (8801 characters) and content confirm it is the report itself, not just an announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2017-12-27 Chinese
关于第一大股东变更的公告
Major Shareholding Notification Classification · 100% confidence The document is a public announcement from a company regarding a change in its largest shareholder. It details the increase in shares held by a particular shareholder and clarifies that this change does not result in a controlling shareholder or actual controller. The document references relevant laws and regulations about shareholder disclosures and states that a detailed equity change report will be disclosed accordingly. The content is focused on notifying the market about a major shareholding change rather than providing financial results, management changes, or other report types. The document length is short (1055 characters) and is clearly an announcement of a shareholding change. Therefore, the appropriate classification is Major Shareholding Notification (MRQ).
2017-12-26 Chinese
关于股东协议转让公司股份公开征集受让方的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the public solicitation of transferees for a shareholder agreement transfer of company shares. It details the background of the company, the number of shares to be transferred, the qualifications required for transferees, the transfer price, application procedures, and approval requirements. There are no financial statements, audit opinions, or detailed financial performance data included. The document is primarily about a share transfer process and solicitation of buyers, which fits the category of Capital/Financing Update (CAP). The document length is 4385 characters, which is relatively short but contains substantive information about a capital transaction rather than just an announcement of a report. Therefore, it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS).
2017-12-14 Chinese

Browse filings by year

29 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.